While smoking is known to boost the risk of chronic obstructive pulmonary disease (COPD), a new study finds that the prevalence of non-smokers with COPD is also growing. The findings of the study are published in the journal Chest.
The global burden of COPD is high, and the prevalence of nonsmokers with COPD has been raising and varies widely across region, area, and nation.
New COPD Management Guidelines from National Institute for Health and Care Excellence (NICE)
The National Institute for Health and Care Excellence (NICE) UK has expanded current criteria for referral of chronic obstructive pulmonary disease (COPD) patients for lung volume reduction due to recent availability of new endobronchial valve treatment.
Advertisement
‘Exposure to environmental pollution, industrial smoke, and household smoke are significant contributors for COPD among nonsmokers.’
Read More..
Tweet it Now
Read More..
In the study, researchers in Nagpur, India, sought to describe the characteristics of nonsmoking patients with COPD and to determine associated comorbidities and exposures.
Researchers examined 180 nonsmoking patients with COPD between the years of 2016 and 2018. Each patient was categorized into either mild, moderate, severe and very severe COPD, based on their responses to Global Initiative for Chronic Obstructive Lung Disease (GOLD) guideline questionnaires.
![New Tool Predicts COPD Patient]( "New Tool Predicts COPD Patient")
New Ottawa Risk Scale predicts chronic obstructive pulmonary disease (COPD) patients at risk of serious complications and will enable emergency room doctors to make better decisions about patient care.
In this cohort, the percentage of mild, moderate, severe and very severe patients were 26%, 53%, 58%, and 43%, respectively. The most common comorbidity among nonsmoker COPD was hypertension (34.4%) followed by diabetes mellitus (17.8%). Most of the patients (61%) lived in rural areas, while 38% belonged to urban areas. Forty-six percent of patients had exposure to biomass gas, while 26% had exposure to toxic gases.
These results support that exposure to biomass fuel is a major contributing factor to COPD and a higher risk among the rural population.
"Exposure to industrial smoke, environmental pollution, and household smoke are major contributors for COPD in nonsmokers," says Dr. Sameer Arbat, lead researcher.
"There is a need to study this subset of nonsmokers having COPD further to determine the true cause of this increase."
Source: Eurekalert
New Tool Predicts COPD Patient's at Risk of Serious Complications
New Ottawa Risk Scale predicts chronic obstructive pulmonary disease (COPD) patients at risk of serious complications and will enable emergency room doctors to make better decisions about patient care.
Advertisement
In this cohort, the percentage of mild, moderate, severe and very severe patients were 26%, 53%, 58%, and 43%, respectively. The most common comorbidity among nonsmoker COPD was hypertension (34.4%) followed by diabetes mellitus (17.8%). Most of the patients (61%) lived in rural areas, while 38% belonged to urban areas. Forty-six percent of patients had exposure to biomass gas, while 26% had exposure to toxic gases.
These results support that exposure to biomass fuel is a major contributing factor to COPD and a higher risk among the rural population.
"Exposure to industrial smoke, environmental pollution, and household smoke are major contributors for COPD in nonsmokers," says Dr. Sameer Arbat, lead researcher.
"There is a need to study this subset of nonsmokers having COPD further to determine the true cause of this increase."
Source: Eurekalert
World COPD Day - ‘Never Too Early, Never Too Late’
World COPD Day is observed annually on every third Wednesday of November by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) to raise awareness about the chronic obstructive pulmonary disease (COPD) and improve COPD care throughout the world.
Advertisement
 Mepolizumab Antibody Therapy to Help Treatment of Resistant COPD PatientsAbout 40% of COPD patients are resistant to standard treatment and continue to have flare ups; mepolizumab, an antibody therapy may help them, says study. | Advertisement
|
Advertisement
Recommended Readings
Latest Respiratory Disease News
According to the Centers for Disease Control and Prevention (CDC), there was a notable increase in infections caused by human metapneumovirus (HMPV), an emerging threat.
The new cell culture technology platform allows researchers to react to the next pandemic with much more speed and precision.
A new artificial intelligence-enabled chest imaging technology performs a deep characterization of the pulmonary vasculature to detect pulmonary (arterial) hypertension.
The global climate crisis is stimulating heat waves to become more frequent causing distress to people with asthma, say experts.
A new study reveals vitamin D3 supplements have encouraging effects for asthma patients. Vitamin D has a positive effect on immune response.